Pfizer’s Turnaround is Gaining Traction, but Can New Products Offset its Patent Cliff?
Pfizer Inc. (NYSE:PFE) is beginning to show signs of steadier growth following the sharp decline in its pandemic-related…
Fundraise or not? Time to decode the growth dilemma for India’s start-ups
The Indian start-up ecosystem is currently witnessing a transformative phase where the definition of success is shifting from…